AVE 0.00% 0.2¢ avecho biotechnology limited

Ann: Avecho receives ethics approval for Phase III CBD trial, page-6

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    I would suggest 6Pounder that positive results would entice a few partners who would have capabilities to commercialise.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.